{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:40:09Z","timestamp":1742935209002,"version":"3.40.3"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["23K16288"],"award-info":[{"award-number":["23K16288"]}]},{"name":"AMED-CREST","award":["JP22gm1610007"],"award-info":[{"award-number":["JP22gm1610007"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec>\n<jats:title>\nBackground\n<\/jats:title>\n<jats:p>Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic. Bacterial coinfections with COVID-19 occur in 3.5% of COVID-19 cases, with a higher incidence in severe cases. Although antibiotics have been prescribed to treat non-critically ill patients with COVID-19, their effect on non-critically ill hospitalized patients with COVID-19 remains uncertain.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>\nMethods\n<\/jats:title>\n<jats:p>We analyzed data from non-critically ill hospitalized patients with COVID-19 who were older than 18 years between January 1, 2020, and May 31, 2023. We performed propensity score matching analysis, evaluating in-hospital mortality with or without antibiotic prescription within 2 days of admission. Sensitivity analyses using inverse probability weighting and generalized estimating equation were also performed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>\nResults\n<\/jats:title>\n<jats:p>Eligible patients (n =\u2009 144,110) were divided into antibiotic prescription (n =\u2009 3,873) and control (n =\u2009 140,237) groups. One-to-one propensity score matching identified 3,861 pairs of patients who received antibiotic prescriptions within 2 days of admission. Following this, antibiotic prescription was associated with a decreased 28-day mortality rate (2.3% vs. 3.6%) and in-hospital mortality rate (4.0% vs. 5.0%) compared with the control group. Conversely, antibiotics increased <jats:italic>Clostridioides difficile<\/jats:italic> infection (CDI) compared with the control group (0.6% vs. 0.1%). No statistical differences were observed between both groups regarding acute kidney injury (0.4% vs. 0.2%). Sensitivity analysis showed similar outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>\nConclusions\n<\/jats:title>\n<jats:p>This multicenter observational study in Japan showed that antibiotic prescriptions were associated with lower 28-day and in-hospital mortalities and an increased CDI risk in non-critically ill hospitalized patients with COVID-19.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0318803","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:12:31Z","timestamp":1742933551000},"page":"e0318803","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of antibiotic prescription in non-critically ill hospitalized patients with COVID-19: A Japanese inpatient database study"],"prefix":"10.1371","volume":"20","author":[{"given":"Haruka","family":"Imai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideya","family":"Itagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6622-2752","authenticated-orcid":true,"given":"Eiichi N.","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"issue":"4","key":"pone.0318803.ref001","first-page":"16402","article-title":"COVID-19 and its long-term sequelae: What do we know in 2023?","volume":"133","author":"G Lippi","year":"2023","journal-title":"Pol Arch Intern Med"},{"issue":"12","key":"pone.0318803.ref002","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/jir.2020.0210","article-title":"Role of host immune and inflammatory responses in COVID-19 cases with underlying primary immunodeficiency: a review","volume":"40","author":"BM Liu","year":"2020","journal-title":"J Interferon Cytokine Res"},{"key":"pone.0318803.ref003","doi-asserted-by":"crossref","first-page":"155478","DOI":"10.1016\/j.cyto.2021.155478","article-title":"Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: a review","volume":"142","author":"M Benjamin","year":"2021","journal-title":"Cytokine"},{"issue":"16","key":"pone.0318803.ref004","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.3390\/jcm12165224","article-title":"Unraveling acute and post-COVID cytokine patterns to anticipate future challenges","volume":"12","author":"M Bekbossynova","year":"2023","journal-title":"J Clin Med"},{"issue":"3","key":"pone.0318803.ref005","doi-asserted-by":"crossref","first-page":"2000173","DOI":"10.1002\/adtp.202000173","article-title":"Management of coronavirus disease 2019 (COVID-19) pandemic: from diagnosis to treatment strategies","volume":"4","author":"Z Hadisi","year":"2021","journal-title":"Adv Ther (Weinh)"},{"issue":"2","key":"pone.0318803.ref006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14740\/jocmr4658","article-title":"\u201cMATH+\u201d multi-modal hospital treatment protocol for COVID-19 infection: clinical and scientific rationale","volume":"14","author":"P Kory","year":"2022","journal-title":"J Clin Med Res"},{"key":"pone.0318803.ref007","doi-asserted-by":"crossref","first-page":"1125246","DOI":"10.3389\/fimmu.2023.1125246","article-title":"The development of COVID-19 treatment","volume":"14","author":"Y Yuan","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0318803.ref008","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/17085381221126235","article-title":"Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? Current controversies","volume":"32","author":"M Porres-Aguilar","year":"2024","journal-title":"Vascular"},{"issue":"6","key":"pone.0318803.ref009","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3390\/antibiotics10060745","article-title":"Antimicrobial use in COVID-19 patients in the first phase of the SARS-CoV-2 pandemic: a scoping review","volume":"10","author":"W Cong","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"Suppl1","key":"pone.0318803.ref010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.37201\/req\/s01.19.2021","article-title":"COVID-19: impact on prescribing and antimicrobial resistance","author":"P Ruiz-Garbajosa","year":"2021","journal-title":"Rev Esp Quimioter"},{"issue":"23","key":"pone.0318803.ref011","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.3390\/jcm11237207","article-title":"Antibiotics use in COVID-19 patients: a systematic literature review","volume":"11","author":"G Granata","year":"2022","journal-title":"J Clin Med"},{"key":"pone.0318803.ref012","first-page":"6687437","article-title":"A review of antibiotic efficacy in COVID-19 control","author":"H Hekmat","year":"2023","journal-title":"J Immunol Res"},{"issue":"12","key":"pone.0318803.ref013","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"BJ Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"pone.0318803.ref014","doi-asserted-by":"crossref","first-page":"e0272375","DOI":"10.1371\/journal.pone.0272375","article-title":"Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis","volume":"17","author":"FS Alshaikh","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"pone.0318803.ref015","doi-asserted-by":"crossref","first-page":"107261","DOI":"10.1016\/j.ijantimicag.2024.107261","article-title":"Evaluation of antibiotic prescriptions based on the AWaRe classification for outpatients with COVID-19 in Japanese hospitals: a retrospective claims database study","volume":"64","author":"J Suzuki","year":"2024","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"pone.0318803.ref016","doi-asserted-by":"crossref","first-page":"22340","DOI":"10.1038\/s41598-022-26780-0","article-title":"Prevalence and characteristics of antibiotic prescription for acute COVID-19 patients in Japan","volume":"12","author":"S Hamada","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"pone.0318803.ref017","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/jamasurg.2019.0569","article-title":"Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events","volume":"154","author":"W Branch-Elliman","year":"2019","journal-title":"JAMA Surg"},{"key":"pone.0318803.ref018"},{"key":"pone.0318803.ref019"},{"issue":"2","key":"pone.0318803.ref020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.37737\/ace.23008","article-title":"A review of studies using Japanese nationwide administrative claims databases","volume":"5","author":"S Sato","year":"2023","journal-title":"Ann Clin Epidemiol"},{"key":"pone.0318803.ref021","volume-title":"Guidelines for clinical practice in response to COVID-19"},{"issue":"2","key":"pone.0318803.ref022","doi-asserted-by":"crossref","first-page":"173","DOI":"10.17219\/dmp\/166666","article-title":"Charlson comorbidity index and the severity of community-acquired pneumonia caused by SARS-CoV-2: A retrospective analysis","volume":"61","author":"M Marushchak","year":"2024","journal-title":"Dent Med Probl"},{"issue":"1","key":"pone.0318803.ref023","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12873-019-0282-x","article-title":"Association of Japan coma scale score on hospital arrival with in-hospital mortality among trauma patients","volume":"19","author":"T Yumoto","year":"2019","journal-title":"BMC Emerg Med"},{"key":"pone.0318803.ref024"},{"issue":"1","key":"pone.0318803.ref025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000510615","article-title":"Pneumonia is associated with increased mortality in hospitalized COPD patients: a systematic review and meta-analysis","volume":"100","author":"Y Yu","year":"2021","journal-title":"Respiration"},{"issue":"9","key":"pone.0318803.ref026","doi-asserted-by":"crossref","first-page":"e0013721","DOI":"10.1128\/JCM.00137-21","article-title":"The brief case: ventilator-associated Corynebacterium accolens pneumonia in a patient with respiratory failure due to COVID-19","volume":"59","author":"M Benjamin","year":"2021","journal-title":"J Clin Microbiol"},{"issue":"7","key":"pone.0318803.ref027","first-page":"926","article-title":"Case 7-2023: a 70-year-old man with Covid-19, respiratory failure, and rashes","volume":"388","author":"K Michael","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0318803.ref028","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10096-024-04755-5","article-title":"Risk factors, outcomes, and epidemiological and etiological study of hospitalized COVID-19 patients with bacterial co-infection and secondary infections","volume":"43","author":"Y Duan","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"pone.0318803.ref029","doi-asserted-by":"crossref","first-page":"ofaa578","DOI":"10.1093\/ofid\/ofaa578","article-title":"Prevalence of co-infection at the time of hospital admission in COVID-19 patients, a multicenter study","volume":"8","author":"SM Karaba","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"pone.0318803.ref030","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1016\/S2666-5247(21)00090-2","article-title":"Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study","volume":"2","author":"CD Russell","year":"2021","journal-title":"Lancet Microbe"},{"issue":"10","key":"pone.0318803.ref031","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","article-title":"Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting","volume":"26","author":"S Hughes","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"pone.0318803.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajem.2021.09.040","article-title":"Bacterial infections and death among patients with Covid-19 versus non Covid-19 patients with pneumonia","volume":"51","author":"H Scott","year":"2022","journal-title":"Am J Emerg Med"},{"issue":"14","key":"pone.0318803.ref033","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. burden of clostridioides difficile infection and outcomes","volume":"382","author":"AY Guh","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0318803.ref034","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/jgh.16128","article-title":"The burden of Clostridioides difficile on COVID-19 hospitalizations in the USA","volume":"38","author":"A Sohal","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"pone.0318803.ref035","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"H Zhang","year":"2020","journal-title":"Intensive Care Med"},{"issue":"3","key":"pone.0318803.ref036","doi-asserted-by":"crossref","first-page":"e2176","DOI":"10.1002\/rmv.2176","article-title":"Covid-19 and kidney injury: pathophysiology and molecular mechanisms","volume":"31","author":"E Ahmadian","year":"2021","journal-title":"Rev Med Virol"},{"issue":"4","key":"pone.0318803.ref037","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/pathogens13040325","article-title":"Are kidneys affected by SARS-CoV-2 infection? An updated review on COVID-19-associated AKI","volume":"13","author":"F Fabrizi","year":"2024","journal-title":"Pathogens"},{"issue":"5","key":"pone.0318803.ref038","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1681\/ASN.2020121768","article-title":"COVID-19 and AKI: Where do we stand?","volume":"32","author":"PM Palevsky","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"pone.0318803.ref039","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12882-024-03498-x","article-title":"A study of hospitalized COVID-19 patients with AKI in a setting of multiracial developing country","volume":"25","author":"SH Ooi","year":"2024","journal-title":"BMC Nephrol"},{"issue":"3","key":"pone.0318803.ref040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3906\/sag-2011-169","article-title":"Impact of hospital-acquired acute kidney injury on Covid-19 outcomes in patients with and without chronic kidney disease: a multicenter retrospective cohort study","volume":"51","author":"S \u00d6zt\u00fcrk","year":"2021","journal-title":"Turk J Med Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:13:56Z","timestamp":1742933636000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318803"}},"subtitle":[],"editor":[{"given":"Benjamin M.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0318803","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]}}}